What You Should Know:
- Teladoc Health and Dexcom announced an expanded
partnership on a new offering measures the impact of continuous glucose
monitoring and real-time health recommendations for people with Type 2 diabetes
at no cost.
Teladoc Health, Inc., the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint Livongo for Diabetes and Dexcom members will now
Read More
4 Predictions for Diabetes Management and Technology in 2021
Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec
The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable
Read More
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack,
Read More
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe
What You Should Know:
- Abbott has received CE Mark (European approval)
for its next-generation FreeStyle Libre 3 system for people with diabetes.
- FreeStyle Libre 3 is the latest advancement from
Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest
continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies)
and a more environmentally sustainable system design.
Abbott, the worldwide
leader in continuous glucose
Read More
Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring
What You Should Know:
- Current Health has partnered with Dexcom to add continuous
glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM)
platform – enhancing care and improving outcomes for diabetics.
- Dexcom CGM data will transmit directly into the Current
Health wearable and platform for review by the care management and clinical
teams, improving post-discharge and chronic care of diabetes patients outside
the hospital.
- Through this partnership, Current
Read More
One Drop Acquires Sano’s Continuous Glucose Sensing Platform
What You Should Know:
- One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano's continuous glucose sensing platform.
- One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
One Drop, a New York
City-based provider of digital care solutions for people
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring
Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More
DarioHealth Integrates Blood Glucose Data with Glytec’s Outpatient Insulin Management Solution
DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More
OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU
OptiScan Biomedical, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU) has raised $20 million in Series E funding. The company plans to use the funding to support the commercialization of the company’s lead product, the OptiScanner 5000, in the United States. OptiScan will also use a portion of the funding to continue the expansion of the company’s OptiScanner platform to monitor additional analytes of interest for critically ill
Read More
